The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
A delayed tendering process for antiretroviral drugs by the Indian National AIDS Control Organisation (NACO) meant that 150,000 people living with HIV (PLHIV) in India were at risk of being without antiretroviral treatment (ART) for October. This is a continuation of the drugs crisis AVERT reported on last month, which saw NACO having issues procuring drugs. Recently, a coalition of Indian pharmaceutical companies, the World Health Organisation (WHO), Medicine San Frontier (MSF) and others have come together to fill the gap of missing drugs.
Self-testing for HIV can be an effective way of increasing uptake of HIV testing and reaching high risk sub-groups of men who have sex with men (MSM) in China. An online survey conducted in China, found that 20.3 percent of MSM in the country had self-tested for HIV at least once in their lives.
HIV drug shortages in India over the past few months have meant that many people living with HIV (PLHIV) are unable to access antiretroviral treatment (ART) through government run distribution centres. Thousands of PLHIV rely on the free ART provided by India’s National AIDS Control Organization (NACO), however they are facing drug shortfalls that are largely blamed on supply bottlenecks, late payments to pharmaceutical companies and Indian manufacturers boycotting the process.
Taiwan has lifted the ban on entry, stay and residence of foreigners living with HIV, as reported in the Taipei Times last week. The new law states that people wishing to stay in Taiwan for more than three months are no longer required to produce a recent HIV test, nor do they risk being deported or having their visas revoked if they find that they are living with HIV.